Who
Matthew Brams
EVP and Chief Medical Officer
Company insider
Files Form 4 as: EVP and Chief Medical Officer, Cingulate.
In numbers
- Trades disclosed
- 24
- Buys
- 1
- Sells
- 0
- Bought
- $20K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 7 Dec 2021
- Last trade
- 16 Jul 2026
- Last filed
- 20 Jul 2026
Companies traded
Activity over time
1 Feb – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 16 Jul 2026filed 20 Jul 2026 | CING Cingulateoption or derivative · Biotechnology | SEC FORM 4 Code A | —53,600 at $0.00 | filing |
| 16 Jul 2026filed 20 Jul 2026 | CING Cingulateoption or derivative · Biotechnology | SEC FORM 4 Code A | —26,400 at $0.00 | filing |
| 16 Jul 2026filed 20 Jul 2026 | CING Cingulateoption or derivative · Biotechnology | SEC FORM 4 Code A | —53,600 at $0.00 | filing |
| 16 Jul 2026filed 20 Jul 2026 | CING Cingulateoption or derivative · Biotechnology | SEC FORM 4 Code A | —26,400 at $0.00 | filing |
| 9 Mar 2026filed 11 Mar 2026 | CING CingulateBiotechnology | SEC FORM 4 Code A | —4,526 at $0.00 | filing |
| 9 Mar 2026filed 11 Mar 2026 | CING CingulateBiotechnology | SEC FORM 4 Code F | —1,025 at $0.00 | filing |
| 9 Mar 2026filed 11 Mar 2026 | CING CingulateBiotechnology | SEC FORM 4 Code A | —4,526 at $0.00 | filing |
| 9 Mar 2026filed 11 Mar 2026 | CING CingulateBiotechnology | SEC FORM 4 Code F | —1,025 at $0.00 | filing |
| 6 Feb 2026filed 10 Feb 2026 | CING CingulateBiotechnology | SEC FORM 4 Bought | $9,8081,946 at $5.04 | filing |
| 6 Feb 2026filed 10 Feb 2026 | CING Cingulateoption or derivative · Biotechnology | SEC FORM 4 Code P | $1561,556 at $0.10 | filing |
| 6 Feb 2026filed 10 Feb 2026 | CING Cingulateoption or derivative · Biotechnology | SEC FORM 4 Code P | $1561,556 at $0.10 | filing |
| 6 Feb 2026filed 10 Feb 2026 | CING CingulateBiotechnology | SEC FORM 4 Bought | $9,8081,946 at $5.04 | filing |
| 7 Jul 2025filed 9 Jul 2025 | CING Cingulateoption or derivative · Biotechnology | SEC FORM 4 Code A | —52,500 at $0.00 | filing |
| 18 Feb 2025filed 20 Feb 2025 | CING Cingulateoption or derivative · Biotechnology | SEC FORM 4 Code A | —17,630 at $0.00 | filing |
| 17 Jan 2025filed 22 Jan 2025 | CING Cingulateoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,748 at $0.00 | filing |
| 31 Dec 2024filed 7 Jan 2025 | CING Cingulateoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,000 at $0.00 | filing |
| 30 Sep 2024filed 1 Oct 2024 | CING Cingulateoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,000 at $0.00 | filing |
| 28 Jun 2024filed 2 Jul 2024 | CING Cingulateoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,000 at $0.00 | filing |
| 11 Jun 2024filed 13 Jun 2024 | CING Cingulateoption or derivative · Biotechnology | SEC FORM 4 Code A | —63,324 at $0.00 | filing |
| 29 Mar 2024filed 1 Apr 2024 | CING Cingulateoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.